nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—Cerebral haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.0228	0.0889	CcSEcCtD
Pseudoephedrine—Paranoia—Riluzole—amyotrophic lateral sclerosis	0.0185	0.0722	CcSEcCtD
Pseudoephedrine—Ventricular fibrillation—Riluzole—amyotrophic lateral sclerosis	0.0165	0.0643	CcSEcCtD
Pseudoephedrine—Delirium—Riluzole—amyotrophic lateral sclerosis	0.0147	0.0572	CcSEcCtD
Pseudoephedrine—SLC6A3—nerve—amyotrophic lateral sclerosis	0.011	0.0493	CbGeAlD
Pseudoephedrine—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.0108	0.0423	CcSEcCtD
Pseudoephedrine—NFATC1—nervous system—amyotrophic lateral sclerosis	0.0103	0.0459	CbGeAlD
Pseudoephedrine—NFATC1—central nervous system—amyotrophic lateral sclerosis	0.00988	0.0442	CbGeAlD
Pseudoephedrine—NFATC1—cerebellum—amyotrophic lateral sclerosis	0.00965	0.0432	CbGeAlD
Pseudoephedrine—IL2—nervous system—amyotrophic lateral sclerosis	0.00938	0.042	CbGeAlD
Pseudoephedrine—IL2—central nervous system—amyotrophic lateral sclerosis	0.00903	0.0404	CbGeAlD
Pseudoephedrine—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00894	0.0349	CcSEcCtD
Pseudoephedrine—SLC6A2—nerve—amyotrophic lateral sclerosis	0.00889	0.0398	CbGeAlD
Pseudoephedrine—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.0087	0.034	CcSEcCtD
Pseudoephedrine—SLC6A3—hindbrain—amyotrophic lateral sclerosis	0.00825	0.0369	CbGeAlD
Pseudoephedrine—MAOA—nerve—amyotrophic lateral sclerosis	0.00819	0.0367	CbGeAlD
Pseudoephedrine—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00806	0.0361	CbGeAlD
Pseudoephedrine—NFATC1—brain—amyotrophic lateral sclerosis	0.00784	0.0351	CbGeAlD
Pseudoephedrine—Angina pectoris—Riluzole—amyotrophic lateral sclerosis	0.0077	0.0301	CcSEcCtD
Pseudoephedrine—SLC6A4—hindbrain—amyotrophic lateral sclerosis	0.00756	0.0339	CbGeAlD
Pseudoephedrine—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.0074	0.0289	CcSEcCtD
Pseudoephedrine—IL2—brain—amyotrophic lateral sclerosis	0.00717	0.0321	CbGeAlD
Pseudoephedrine—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00676	0.0264	CcSEcCtD
Pseudoephedrine—Bradycardia—Riluzole—amyotrophic lateral sclerosis	0.00644	0.0252	CcSEcCtD
Pseudoephedrine—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.0063	0.0246	CcSEcCtD
Pseudoephedrine—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.00619	0.0277	CbGeAlD
Pseudoephedrine—MAOA—hindbrain—amyotrophic lateral sclerosis	0.00614	0.0275	CbGeAlD
Pseudoephedrine—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.00565	0.0221	CcSEcCtD
Pseudoephedrine—Tension—Riluzole—amyotrophic lateral sclerosis	0.00541	0.0211	CcSEcCtD
Pseudoephedrine—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00535	0.0209	CcSEcCtD
Pseudoephedrine—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.0053	0.0207	CcSEcCtD
Pseudoephedrine—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00516	0.0202	CcSEcCtD
Pseudoephedrine—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00506	0.0198	CcSEcCtD
Pseudoephedrine—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00495	0.0193	CcSEcCtD
Pseudoephedrine—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00487	0.019	CcSEcCtD
Pseudoephedrine—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00476	0.0186	CcSEcCtD
Pseudoephedrine—SLC6A3—brainstem—amyotrophic lateral sclerosis	0.00473	0.0212	CbGeAlD
Pseudoephedrine—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00469	0.0183	CcSEcCtD
Pseudoephedrine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00468	0.0183	CcSEcCtD
Pseudoephedrine—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00453	0.0177	CcSEcCtD
Pseudoephedrine—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.00439	0.0171	CcSEcCtD
Pseudoephedrine—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00435	0.017	CcSEcCtD
Pseudoephedrine—SLC6A4—brainstem—amyotrophic lateral sclerosis	0.00434	0.0194	CbGeAlD
Pseudoephedrine—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00429	0.0167	CcSEcCtD
Pseudoephedrine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00407	0.0159	CcSEcCtD
Pseudoephedrine—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00401	0.0157	CcSEcCtD
Pseudoephedrine—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00396	0.0155	CcSEcCtD
Pseudoephedrine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00391	0.0153	CcSEcCtD
Pseudoephedrine—Pain—Riluzole—amyotrophic lateral sclerosis	0.00385	0.015	CcSEcCtD
Pseudoephedrine—MAOA—embryo—amyotrophic lateral sclerosis	0.00384	0.0172	CbGeAlD
Pseudoephedrine—SLC6A2—brainstem—amyotrophic lateral sclerosis	0.00382	0.0171	CbGeAlD
Pseudoephedrine—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00371	0.0145	CcSEcCtD
Pseudoephedrine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00365	0.0163	CbGeAlD
Pseudoephedrine—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00356	0.0139	CcSEcCtD
Pseudoephedrine—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.00355	0.0159	CbGeAlD
Pseudoephedrine—MAOA—brainstem—amyotrophic lateral sclerosis	0.00352	0.0157	CbGeAlD
Pseudoephedrine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00323	0.0126	CcSEcCtD
Pseudoephedrine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00297	0.0116	CcSEcCtD
Pseudoephedrine—SLC6A3—spinal cord—amyotrophic lateral sclerosis	0.00294	0.0132	CbGeAlD
Pseudoephedrine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00286	0.0112	CcSEcCtD
Pseudoephedrine—Rash—Riluzole—amyotrophic lateral sclerosis	0.00284	0.0111	CcSEcCtD
Pseudoephedrine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00283	0.0111	CcSEcCtD
Pseudoephedrine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00282	0.011	CcSEcCtD
Pseudoephedrine—SLC6A4—spinal cord—amyotrophic lateral sclerosis	0.0027	0.0121	CbGeAlD
Pseudoephedrine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00267	0.0104	CcSEcCtD
Pseudoephedrine—SLC6A2—medulla oblongata—amyotrophic lateral sclerosis	0.00266	0.0119	CbGeAlD
Pseudoephedrine—SLC6A3—nervous system—amyotrophic lateral sclerosis	0.00248	0.0111	CbGeAlD
Pseudoephedrine—MAOA—medulla oblongata—amyotrophic lateral sclerosis	0.00245	0.011	CbGeAlD
Pseudoephedrine—SLC6A3—central nervous system—amyotrophic lateral sclerosis	0.00239	0.0107	CbGeAlD
Pseudoephedrine—ADRB1—nervous system—amyotrophic lateral sclerosis	0.00235	0.0105	CbGeAlD
Pseudoephedrine—SLC6A3—cerebellum—amyotrophic lateral sclerosis	0.00233	0.0104	CbGeAlD
Pseudoephedrine—SLC6A4—nervous system—amyotrophic lateral sclerosis	0.00227	0.0102	CbGeAlD
Pseudoephedrine—ADRB1—central nervous system—amyotrophic lateral sclerosis	0.00226	0.0101	CbGeAlD
Pseudoephedrine—SLC6A4—central nervous system—amyotrophic lateral sclerosis	0.00219	0.00979	CbGeAlD
Pseudoephedrine—MAOA—spinal cord—amyotrophic lateral sclerosis	0.00219	0.00979	CbGeAlD
Pseudoephedrine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00209	0.00935	CbGeAlD
Pseudoephedrine—SLC6A2—nervous system—amyotrophic lateral sclerosis	0.002	0.00895	CbGeAlD
Pseudoephedrine—SLC6A2—central nervous system—amyotrophic lateral sclerosis	0.00193	0.00862	CbGeAlD
Pseudoephedrine—SLC6A3—brain—amyotrophic lateral sclerosis	0.00189	0.00848	CbGeAlD
Pseudoephedrine—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00188	0.00842	CbGeAlD
Pseudoephedrine—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.00186	0.00832	CbGeAlD
Pseudoephedrine—MAOA—nervous system—amyotrophic lateral sclerosis	0.00184	0.00825	CbGeAlD
Pseudoephedrine—ADRB1—brain—amyotrophic lateral sclerosis	0.0018	0.00804	CbGeAlD
Pseudoephedrine—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.00179	0.00801	CbGeAlD
Pseudoephedrine—MAOA—central nervous system—amyotrophic lateral sclerosis	0.00177	0.00794	CbGeAlD
Pseudoephedrine—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.00175	0.00783	CbGeAlD
Pseudoephedrine—SLC6A4—brain—amyotrophic lateral sclerosis	0.00174	0.00777	CbGeAlD
Pseudoephedrine—MAOA—cerebellum—amyotrophic lateral sclerosis	0.00173	0.00776	CbGeAlD
Pseudoephedrine—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.00168	0.00751	CbGeAlD
Pseudoephedrine—SLC6A2—brain—amyotrophic lateral sclerosis	0.00153	0.00684	CbGeAlD
Pseudoephedrine—ADRA1A—brain—amyotrophic lateral sclerosis	0.00142	0.00636	CbGeAlD
Pseudoephedrine—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.00141	0.00633	CbGeAlD
Pseudoephedrine—MAOA—brain—amyotrophic lateral sclerosis	0.00141	0.0063	CbGeAlD
Pseudoephedrine—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.00136	0.00609	CbGeAlD
Pseudoephedrine—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.00133	0.00595	CbGeAlD
Pseudoephedrine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.00109	0.0049	CbGeAlD
Pseudoephedrine—ADRA2A—brain—amyotrophic lateral sclerosis	0.00108	0.00484	CbGeAlD
Pseudoephedrine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.00105	0.00472	CbGeAlD
Pseudoephedrine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.00103	0.00461	CbGeAlD
Pseudoephedrine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000837	0.00375	CbGeAlD
Pseudoephedrine—NFATC1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000425	0.000817	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—CASP3—amyotrophic lateral sclerosis	0.000424	0.000816	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000421	0.000808	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.00042	0.000808	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—ATF1—amyotrophic lateral sclerosis	0.000419	0.000806	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000418	0.000804	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000405	0.000779	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CASP9—amyotrophic lateral sclerosis	0.000399	0.000767	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000396	0.00076	CbGpPWpGaD
Pseudoephedrine—TNF—TNF alpha Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.000395	0.000758	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000391	0.000752	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.000389	0.000747	CbGpPWpGaD
Pseudoephedrine—TNF—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	0.000378	0.000727	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000378	0.000726	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—CASP9—amyotrophic lateral sclerosis	0.000369	0.000708	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000368	0.000708	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.000363	0.000698	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000362	0.000695	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000362	0.000695	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00036	0.000692	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00036	0.000691	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000356	0.000684	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—ATF1—amyotrophic lateral sclerosis	0.000355	0.000681	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000352	0.000677	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000351	0.000674	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—PTGS2—amyotrophic lateral sclerosis	0.000348	0.000669	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—ERBB4—amyotrophic lateral sclerosis	0.000342	0.000657	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CASP9—amyotrophic lateral sclerosis	0.000338	0.000649	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000336	0.000647	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000336	0.000647	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000331	0.000636	CbGpPWpGaD
Pseudoephedrine—TNF—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.00033	0.000634	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	0.000323	0.000621	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000321	0.000617	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—ERBB4—amyotrophic lateral sclerosis	0.000315	0.000606	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	0.000313	0.000602	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000308	0.000591	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	0.000306	0.000587	CbGpPWpGaD
Pseudoephedrine—SLC6A2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.0003	0.000576	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000299	0.000575	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000298	0.000573	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000298	0.000573	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000298	0.000572	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000297	0.000572	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—RAB5A—amyotrophic lateral sclerosis	0.000291	0.000559	CbGpPWpGaD
Pseudoephedrine—IL2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000289	0.000556	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000289	0.000556	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—ERBB4—amyotrophic lateral sclerosis	0.000289	0.000555	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000289	0.000555	CbGpPWpGaD
Pseudoephedrine—TNF—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	0.000286	0.000549	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000286	0.000549	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—C3—amyotrophic lateral sclerosis	0.000284	0.000546	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—PFN1—amyotrophic lateral sclerosis	0.000282	0.000542	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.000277	0.000532	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—amyotrophic lateral sclerosis	0.000272	0.000523	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000272	0.000522	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000271	0.000521	CbGpPWpGaD
Pseudoephedrine—SLC6A3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000266	0.000511	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	0.000264	0.000508	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000263	0.000505	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—DAO—amyotrophic lateral sclerosis	0.000262	0.000503	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—CASP3—amyotrophic lateral sclerosis	0.00026	0.0005	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000259	0.000497	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000258	0.000496	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000254	0.000488	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000245	0.000472	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000244	0.00047	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—APOE—amyotrophic lateral sclerosis	0.000244	0.000469	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.000244	0.000468	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000242	0.000464	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000242	0.000464	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—C3—amyotrophic lateral sclerosis	0.00024	0.000461	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	0.000237	0.000456	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000237	0.000455	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.00023	0.000442	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000229	0.00044	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000221	0.000425	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000221	0.000425	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.00022	0.000423	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000219	0.000422	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000218	0.00042	CbGpPWpGaD
Pseudoephedrine—ADRA1A—AMPK Signaling—TP53—amyotrophic lateral sclerosis	0.000217	0.000418	CbGpPWpGaD
Pseudoephedrine—ADRB1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000211	0.000406	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000208	0.0004	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000208	0.0004	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000208	0.000399	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	0.000207	0.000398	CbGpPWpGaD
Pseudoephedrine—ADRB2—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000206	0.000397	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000206	0.000395	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000205	0.000395	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000204	0.000391	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000203	0.000389	CbGpPWpGaD
Pseudoephedrine—ADRA2A—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.0002	0.000383	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000198	0.000381	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000193	0.000371	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000189	0.000363	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000187	0.000359	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000187	0.000359	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000185	0.000355	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000184	0.000353	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GSR—amyotrophic lateral sclerosis	0.000183	0.000351	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000176	0.000338	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—DAO—amyotrophic lateral sclerosis	0.000175	0.000336	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000174	0.000334	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000171	0.000328	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000171	0.000328	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000168	0.000324	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—PTGS2—amyotrophic lateral sclerosis	0.000167	0.000321	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—amyotrophic lateral sclerosis	0.000167	0.00032	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	0.000161	0.00031	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000161	0.000309	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000159	0.000305	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000157	0.000303	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000157	0.000303	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000157	0.000302	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	0.000157	0.000301	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000156	0.000301	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—TP53—amyotrophic lateral sclerosis	0.000156	0.0003	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000155	0.000298	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000153	0.000294	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00015	0.000289	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000147	0.000283	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000145	0.000278	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000144	0.000277	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000144	0.000277	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.000142	0.000273	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000141	0.000271	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000141	0.000271	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000138	0.000266	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.000136	0.000262	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000135	0.00026	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000134	0.000257	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000132	0.000254	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000131	0.000252	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.00013	0.00025	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000128	0.000247	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000127	0.000244	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000126	0.000242	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000124	0.000239	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000122	0.000235	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GSR—amyotrophic lateral sclerosis	0.000122	0.000235	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000121	0.000232	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000119	0.00023	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000119	0.000229	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	0.000114	0.000219	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000113	0.000217	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000112	0.000215	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000112	0.000214	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000111	0.000213	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00011	0.000212	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000109	0.00021	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000109	0.000209	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000106	0.000204	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000105	0.000202	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000104	0.0002	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000103	0.000198	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000103	0.000197	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CHAT—amyotrophic lateral sclerosis	0.0001	0.000193	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—VCP—amyotrophic lateral sclerosis	9.87e-05	0.00019	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—MMP9—amyotrophic lateral sclerosis	9.72e-05	0.000187	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	9.56e-05	0.000184	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	9.33e-05	0.000179	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	9.22e-05	0.000177	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	9.19e-05	0.000177	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	9.13e-05	0.000176	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	9.13e-05	0.000175	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	9.08e-05	0.000175	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	9.03e-05	0.000174	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	8.88e-05	0.000171	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	8.73e-05	0.000168	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	8.69e-05	0.000167	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	8.63e-05	0.000166	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	8.49e-05	0.000163	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	8.39e-05	0.000161	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—IGF1—amyotrophic lateral sclerosis	8.31e-05	0.00016	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	8.25e-05	0.000158	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.07e-05	0.000155	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—C3—amyotrophic lateral sclerosis	8.07e-05	0.000155	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	7.96e-05	0.000153	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	7.8e-05	0.00015	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.67e-05	0.000147	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	7.55e-05	0.000145	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	7.5e-05	0.000144	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.42e-05	0.000143	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	7.35e-05	0.000141	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.19e-05	0.000138	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	7.04e-05	0.000135	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	7.02e-05	0.000135	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	6.97e-05	0.000134	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.85e-05	0.000132	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	6.83e-05	0.000131	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	6.7e-05	0.000129	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	6.67e-05	0.000128	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	6.54e-05	0.000126	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	6.21e-05	0.000119	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—C3—amyotrophic lateral sclerosis	6.2e-05	0.000119	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—APOE—amyotrophic lateral sclerosis	6.1e-05	0.000117	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	5.9e-05	0.000113	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.86e-05	0.000113	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.82e-05	0.000112	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.77e-05	0.000111	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	5.74e-05	0.00011	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.54e-05	0.000107	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.51e-05	0.000106	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	5.43e-05	0.000104	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.41e-05	0.000104	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.39e-05	0.000104	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	5.39e-05	0.000104	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.15e-05	9.9e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.96e-05	9.52e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.87e-05	9.36e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—C3—amyotrophic lateral sclerosis	4.77e-05	9.16e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.74e-05	9.12e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.54e-05	8.72e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.46e-05	8.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	4.44e-05	8.53e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.41e-05	8.47e-05	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.18e-05	8.04e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.14e-05	7.96e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	4.1e-05	7.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	4.08e-05	7.84e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.94e-05	7.58e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.75e-05	7.2e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.67e-05	7.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.67e-05	7.05e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.66e-05	7.04e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.51e-05	6.75e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.41e-05	6.55e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.23e-05	6.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.03e-05	5.83e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.88e-05	5.54e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.82e-05	5.42e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.82e-05	5.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.79e-05	5.37e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.73e-05	5.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.67e-05	5.12e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	2.66e-05	5.11e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.45e-05	4.7e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.39e-05	4.6e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.33e-05	4.49e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.21e-05	4.24e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.17e-05	4.17e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.05e-05	3.94e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.98e-05	3.81e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.85e-05	3.55e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.84e-05	3.54e-05	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.82e-05	3.5e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.81e-05	3.48e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.5e-05	2.88e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.39e-05	2.67e-05	CbGpPWpGaD
